Perspectives on cancer chemoprevention research and drug development.
Kelloff
G J
GJ
Chemoprevention Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D016588:Anticarcinogenic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000975:Antioxidants / Q000494:pharmacology; D047072:Aromatase Inhibitors; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D020847:Estrogen Receptor Modulators / Q000494:pharmacology; D011905:Genes, ras; D006801:Humans; D009369:Neoplasms / Q000209:etiology / Q000517:prevention & control*; D017368:Protein Prenylation; D012176:Retinoids / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D016588:Anticarcinogenic Agents; D000975:Antioxidants; D047072:Aromatase Inhibitors; D020847:Estrogen Receptor Modulators; D012176:Retinoids; D066246:ErbB Receptors